SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,000 | +20.7% | 10,119 | +61.3% | 0.00% | – |
| Q2 2023 | $29,000 | +61.1% | 6,275 | +57.4% | 0.00% | – |
| Q1 2023 | $18,000 | -70.0% | 3,986 | -46.5% | 0.00% | – |
| Q4 2022 | $60,000 | +1900.0% | 7,451 | +1150.2% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 596 | +141.3% | 0.00% | – |
| Q2 2022 | $1,000 | -96.2% | 247 | -92.1% | 0.00% | – |
| Q1 2022 | $26,000 | -80.3% | 3,133 | -64.9% | 0.00% | – |
| Q4 2021 | $132,000 | +428.0% | 8,920 | +571.2% | 0.00% | – |
| Q3 2021 | $25,000 | +212.5% | 1,329 | +206.2% | 0.00% | – |
| Q2 2021 | $8,000 | -87.1% | 434 | -84.0% | 0.00% | – |
| Q1 2021 | $62,000 | +520.0% | 2,716 | +462.3% | 0.00% | – |
| Q4 2020 | $10,000 | – | 483 | +1912.5% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 24 | -97.9% | 0.00% | – |
| Q1 2020 | $12,000 | +9.1% | 1,159 | +17.2% | 0.00% | – |
| Q4 2019 | $11,000 | – | 989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |